Filing Details
- Accession Number:
- 0001437749-21-027332
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-11-23 18:40:04
- Reporting Period:
- 2021-11-19
- Accepted Time:
- 2021-11-23 18:40:04
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1603454 | Celcuity Inc. | CELC | Services-Medical Laboratories (8071) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1688319 | E Richard Buller | 16305 36Th Avenue North Suite 100 Minneapolis MN 55446 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-11-19 | 250 | $16.15 | 9,075 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-11-22 | 250 | $15.55 | 8,825 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | $10.68 | 2029-12-03 | 4,555 | 4,555 | Direct | |
Common Stock | Stock Option (right to buy) | $5.10 | 2030-05-14 | 12,654 | 12,654 | Direct | |
Common Stock | Stock Option (right to buy) | $26.99 | 2031-05-12 | 2,310 | 2,310 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2029-12-03 | 4,555 | 4,555 | Direct |
2030-05-14 | 12,654 | 12,654 | Direct |
2031-05-12 | 2,310 | 2,310 | Direct |
Footnotes
- Includes 1,482 shares of restricted stock for which risks of forfeiture lapse on April 30, 2022, or if earlier, the date of the Company's 2022 Annual Meeting of Stockholders.
- 100% vested.
- This option will vest and become exercisable on April 30, 2022, or if earlier, the date of the Company's 2022 Annual Meeting of Stockholders.